Surgify Safety Burrs for safer bone surgery

Informations projet

SSB2

N° de convention de subvention: 190102751

DOI

10.3030/190102751

Projet clôturé

Date de signature de la CE 11 Janvier 2023

Date de début 1 Septembre 2022

Date de fin 31 Août 2024

Financé au titre de

• The European Innovation Council (EIC)

Coût total

€ 3 484 825,00

Contribution de l’UE

€ 2 439 377,50

Coordonné par

SURGIFY MEDICAL OY
Finland

Periodic Reporting for period 2 - SSB2 (Surgify Safety Burrs for safer bone surgery)

Période du rapport: 2023-09-01 au 2024-08-31

Résumé du contexte et des objectifs généraux du projet

6 out of 15 top surgical procedures include bone cutting, which are performed using surgical power tools such as high-speed drills. These drills are widely used in neurosurgery, otology (ear), and spinal procedures, which include some of the most demanding surgical bone operations. However, 30% of bone drilling surgeries can lead to severe soft tissue injury. Missing a target by only millimetres or applying slightly too much force can lead to severe complications threatening patients’ life.

The revolutionary Surgify Safety Burr enables surgeons to cut bone accurately and efficiently without compromising the safety of important soft structures. Thanks to the scalable technology, the safety feature can be customized for a wide range of applications e.g. orthopaedics, pediatrics or even robotics-assisted surgery. During the EIC project, Surgify Safety Burr product platform was designed, developed and commercialized to allow safer surgeries for everyone.

Travail effectué depuis le début du projet jusqu’à la fin de la période considérée dans le rapport et principaux résultats atteints jusqu’à présent

The main goal of the project was to design and develop Surgify Safety Burr product platform to reduce the existing huge medical error in bone-drilling surgeries and make them safe.

By the end of the project, we had managed to develop two different product variations of our safety burr (5,4 mm and 4 mm). The reasoning to have two different products came directly from the surgeons to meet their needs in different drilling scenarios covering spinal surgeries, bone surgeries and extremely small bone structures in paediatrics. To make the surgeries even more safe we also developed a sensor solution to predict and detect breakthrough moments during bone surgeries to avoid damaging the soft tissue in the drilling process. We established a partnership with an established console manufacturer (Nouvag) to get the maximum effect of our Safety Burr with data analytics.

In parallel we modified our product design and increased the durability of the burr from 5 minutes to 10 minutes and optimized our production process reducing thus the cost per piece by 40 %. In our burr production we managed to establish partnerships with GMI Corporation and Montemurro Utensili. We developed our in-house assembly capacity, doubling our production capacity.

During the project we conducted clinical trials together with Kuopio University Hospital and Helsinki University Hospital. As a result of these studies the product received a CE mark and very positive feedback from European surgeons. During the project course we also received the FDA clearance and now we have the permission to sell our safety burr around Europe and US.

Progrès au-delà de l’état des connaissances et impact potentiel prévu (y compris l’impact socio-économique et les conséquences sociétales plus larges du projet jusqu’à présent)

To ensure the success of our project, we are continuously developing our product design. By dedicating ourselves to ongoing design improvements and thorough research into alternative features, we enhance our ability to meet our customers’ evolving demands. This proactive approach not only positions us as more appealing in the market but also ensures our competitiveness in the field.

Surgify logo